<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03277599</url>
  </required_header>
  <id_info>
    <org_study_id>2011-KAEK-25 2016/21-02</org_study_id>
    <nct_id>NCT03277599</nct_id>
  </id_info>
  <brief_title>Comparison of Two Pain-treatment Techniques After Tympanomastoid Surgery Pain</brief_title>
  <official_title>Ultrasound Guided Superficial Cervical Plexus Block Versus Greater Auricular Nerve Block for Tympanomastoid Surgery Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bursa Yüksek İhtisas Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bursa Yüksek İhtisas Education and Research Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Analgesia following tympanomastoid surgery is critical for the prevention of postoperative .
      There are very few regional anesthesia methods used to achieve this goal.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, it was aimed to investigate the effect of Ultrasound guided superficial
      cervical plexus block versus greater auricular nerve block for on postoperative
      tympanomastoid surgery analgesia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 5, 2016</start_date>
  <completion_date type="Actual">July 7, 2017</completion_date>
  <primary_completion_date type="Actual">December 5, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>prospective,randomized,single blind</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analog Pain Scale</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>Visual Analog Pain Scale was used for pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>tramadol consumption</measure>
    <time_frame>Postoperative 24 hour</time_frame>
    <description>tramadol consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>side effect profile</measure>
    <time_frame>Postoperative 24 hour</time_frame>
    <description>side effect profile (including nausea and vomiting, hypotension,requirement and the Ramsay Sedation Scale (RSS) scores)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>additional analgesic use</measure>
    <time_frame>Postoperative 24 hour</time_frame>
    <description>additional analgesic use</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Pain Management</condition>
  <condition>Nerve Block</condition>
  <condition>Ultrasound</condition>
  <arm_group>
    <arm_group_label>Grup Y</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ultrasound guided superficial cervical plexus blockage with 10 ml % 0.25 bupivacaine+IV patient-controlled analgesia (PCA) tramadol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Grup B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ultrasound ultrasound guided Great Auricular nerve blockage with 5 ml % 0.25 bupivacaine +IV patient-controlled analgesia (PCA) tramadol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV patient-controlled analgesia (PCA) tramadol</intervention_name>
    <description>Tramadol infusion (PCA): 400 mg tramadol, IV 4 mg/mL tramadol solution into 100 mL normal saline; PCA settings: 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.</description>
    <arm_group_label>Grup Y</arm_group_label>
    <arm_group_label>Grup B</arm_group_label>
    <other_name>Tramadol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ultrasound guided superficial cervical plexus block</intervention_name>
    <description>ultrasound guided superficial cervical plexus blockage with 10 ml % 0.25 bupivacaine</description>
    <arm_group_label>Grup Y</arm_group_label>
    <other_name>superficial cervical plexus block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ultrasound guided Great Auricular nerve block</intervention_name>
    <description>ultrasound guided Great Auricular nerve blockage with 5 ml % 0.25 bupivacaine +IV patient-controlled analgesia (PCA) tramadol</description>
    <arm_group_label>Grup B</arm_group_label>
    <other_name>Great Auricular nerve block</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who were in the American Society of Anesthesiologists (ASA) I-III class and
             underwent Tympanomastoid surgery.

        Exclusion Criteria:

          -  Previous history of opioid use preoperatively,

          -  Allergy to local anesthetics,

          -  The presence of any systemic infection,

          -  Uncontrolled arterial hypertension,

          -  Uncontrolled diabetes mellitus.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Korgün Ökmen, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospita</affiliation>
  </overall_official>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2017</study_first_submitted>
  <study_first_submitted_qc>September 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 11, 2017</study_first_posted>
  <last_update_submitted>March 19, 2018</last_update_submitted>
  <last_update_submitted_qc>March 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bursa Yüksek İhtisas Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Korgün Ökmen</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Tramadol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

